Serial production of the Russian coronavirus vaccine Sputnik V has started in Uzbekistan at Jurabek Laboratories, which expects to start supplying it to the Uzbek market in October. This was reported on Tuesday by Gazeta.uz citing the head of the marketing and sales department of Jurabek Laboratories Aziz Saipov.
"The bottling has already started. We send each series to Russia for control. The analysis takes about three weeks. Control is going on in Russia and in the laboratory of the state center (Uzbekistan - TASS) in parallel. As soon as we get the answers, we will be able to ship [the vaccine to the Uzbek Health Ministry]," Saipov was quoted as saying by the newspaper. The company representative said that the drug will arrive on the domestic market in October.
According to Saipov, samples of the Sputnik V vaccine serially produced in Uzbekistan were sent for quality control to the drug developer, the Russian Gamaleya National Research Center for Epidemiology and Microbiology, as well as to the State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment at the Pharmaceutical Industry Development Agency of Uzbekistan.
The first batch of the Sputnik V vaccine was produced at Jurabek Laboratories plant in Almalyk city of Tashkent region of Uzbekistan, the Russian Direct Investment Fund (RDIF) said in late July. The capacity of the plant is 2 million doses of Sputnik V per month.
Mass vaccination of the population in Uzbekistan began in April. As part of the vaccination campaign, the Russian vaccine Sputnik V, a drug manufactured in India under license from the British-Swedish company AstraZeneca, a vaccine from the Chinese company Anhui Zhifei Longcom Biopharmaceutical and a drug from the American company Moderna are used. According to the latest data, more than 3.12 million people in the country with a population of about 35 million have been fully vaccinated, and almost 10 million people have received the first component of one of the vaccines.
GSV "Russia - Islamic World"
Photo: sputnikvaccine.com
Based on materials from TASS